1. Home
  2. CPHI vs OGEN Comparison

CPHI vs OGEN Comparison

Compare CPHI & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • OGEN
  • Stock Information
  • Founded
  • CPHI N/A
  • OGEN 1996
  • Country
  • CPHI China
  • OGEN United States
  • Employees
  • CPHI N/A
  • OGEN N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPHI Health Care
  • OGEN Health Care
  • Exchange
  • CPHI Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • CPHI 4.2M
  • OGEN 4.5M
  • IPO Year
  • CPHI N/A
  • OGEN N/A
  • Fundamental
  • Price
  • CPHI $0.19
  • OGEN $0.28
  • Analyst Decision
  • CPHI
  • OGEN
  • Analyst Count
  • CPHI 0
  • OGEN 0
  • Target Price
  • CPHI N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • CPHI 380.9K
  • OGEN 635.1K
  • Earning Date
  • CPHI 11-13-2024
  • OGEN 11-13-2024
  • Dividend Yield
  • CPHI N/A
  • OGEN N/A
  • EPS Growth
  • CPHI N/A
  • OGEN N/A
  • EPS
  • CPHI N/A
  • OGEN N/A
  • Revenue
  • CPHI $5,544,620.00
  • OGEN N/A
  • Revenue This Year
  • CPHI N/A
  • OGEN N/A
  • Revenue Next Year
  • CPHI N/A
  • OGEN N/A
  • P/E Ratio
  • CPHI N/A
  • OGEN N/A
  • Revenue Growth
  • CPHI N/A
  • OGEN N/A
  • 52 Week Low
  • CPHI $0.17
  • OGEN $0.25
  • 52 Week High
  • CPHI $1.15
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 36.69
  • OGEN 38.50
  • Support Level
  • CPHI $0.18
  • OGEN $0.25
  • Resistance Level
  • CPHI $0.21
  • OGEN $0.43
  • Average True Range (ATR)
  • CPHI 0.02
  • OGEN 0.04
  • MACD
  • CPHI -0.00
  • OGEN 0.00
  • Stochastic Oscillator
  • CPHI 16.25
  • OGEN 17.78

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: